Zhongguancun Life Science Park Venture Capital Fund, an important part of the fund system of the Zhongguancun Development Group, has been committed to the incubation and service of original innovation projects since its establishment two years ago, supporting scientists and entrepreneurs with research discoveries and technological innovations and promoting project transformation. So far, the fund has invested in 20 companies.

Pyrotech Therapeutics is a biopharmaceutical company focusing on frontier basic research into innate immunity and pyroptosis. The First-in-Class products it develops provide advanced methods for clinical treatment. 

In 2021, Life Park Ventures incubated and invested in this company on behalf of Zhongguancun Life Science Park. 

With the support of the fund, Pyrotech Therapeutics settled in the Life Park in early 2021. Its R&D center, covering an area of 400 square meters and meeting international standards, was put into use that year. Currently, nearly 90 scientific researchers have carried out a number of international new drug research and development projects with new targets here.

The park is now home to eight national engineering centers including the Beijing Institute of Life Sciences and the Beijing Brain Science and Brain-Inspired Research Center, a s well as more than 500 innovative pharmaceutical companies and 22 post-doctoral scientific research workstations.